Mitchell A. Baran

Mitchell Baran is Chairman of Trudell Medical Group, a family owned global healthcare company that carries on activities in product development, manufacturing and distribution of medical products in Canada, the US and internationally.  Mr. Baran is past Chairman of the Medical Devices Advisory Council, a Government of Canada initiative to promote competitiveness in the Canadian medical devices industry and Med Tech, an exposition designed to showcase innovative Canadian medical devices and assist researchers and inventors to bring their products to market.  He is also a past member of the Ontario Health Industry Advisory Committee (HIAC) and the Health Industries Development Council (HIDCO), both medical industry initiatives of the Province of Ontario.  Mr. Baran is director of a number of Canadian and US companies and has been a member of Viron’s Board of Directors since the company’s inception.   Mr. Baran, an alumnus of the University of Western Ontario’s Ivey School of Business, is also a Chartered Accountant and has been inducted as a Fellow of the Ontario Institute of Chartered Accountants.

Dr. Ho Sung Cho

Ho Sung Cho is Chief Technology Officer at Ambrx Pharmaceutical.  Dr. Cho has over 15 years of experience in recombinant protein expression, purification, modification, and analysis. Prior to joining Ambrx, he served as the Associate Director of Protein Chemistry at Xencor where he modernized the department's capabilities in high throughput protein expression and purification, and developed a strategy for protein PEGylation applied to the first clinical candidate. Prior to Xencor, Dr. Cho was at Exelixis where he was the Team Leader responsible for all internal protein needs for HTP screening and structural biology. Prior to joining industry, Dr. Cho was a staff scientist at Lawrence Berkeley National Labs where he worked on the structural genomics project, applying NMR spectroscopy and X-ray crystallography to determine structures of proteins at atomic resolution. In addition to his interest in proteins, Dr. Cho has a strong affinity for synthetic chemistry as he began his scientific career as a medicinal chemist in the Oncology Department at Burroughs Wellcome, RTP.

Joseph Regan

Joseph Regan is a Vice President, Investments at GrowthWorks Capital. Mr. Regan joined GrowthWorks in early 2003, bringing over a decade of life sciences venture capital and pharmaceutical industry experience. He has been active in both company creation and the strategic growth of portfolio companies. Mr. Regan currently serves on a number of GrowthWorks’ investee Boards and Funds. Joe has an Honours BSc (with distinction) from the University of Guelph and an MBA (Dean's List) from McMaster University.

James M. Rae